Atezolizumab in combination with bevacizumab and chemotherapy versus bevacizumab and chemotherapy in recurrent ovarian cancer – a randomized phase III trial (AGO-OVAR 2.29/ENGOT-ov34)
Titel:
Atezolizumab in combination with bevacizumab and chemotherapy versus bevacizumab and chemotherapy in recurrent ovarian cancer – a randomized phase III trial (AGO-OVAR 2.29/ENGOT-ov34)
Auteur:
Harter, Philipp Pautier, Patricia Van Nieuwenhuysen, Els Reuss, Alexander Redondo, Andres Lindemann, Kristina Kurzeder, Christian Petru, Edgar Heitz, Florian Sehouli, Jalid Degregorio, Nikolaus Wimberger, Pauline Burges, Alexander Cron, Nadin Ledermann, Jonathan Lorusso, Domenica Paoletti, Xavier Marme, Frederik
Verschenen in:
International journal of gynecological cancer
Paginering:
Jaargang 30 () nr. 12 pagina's 1997-2001
Jaar:
2020
Inhoud:
Uitgever:
IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ.